Anebulo Pharmaceuticals | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Officer Cundy Kenneth C
Mar 8 21:10
Anebulo Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Cundy Kenneth C
Mar 2 07:25
Anebulo Pharmaceuticals | 10-Q: Quarterly report
Feb 14 05:38
Anebulo Pharmaceuticals | 8-K: Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2024 Financial Results and Recent Updates
Feb 14 05:24
Anebulo Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director English Aron R.
Dec 21, 2023 05:22
Anebulo Pharmaceuticals | 8-K: Current report
Nov 22, 2023 05:01
Anebulo Pharmaceuticals: Q1 2024 Earnings Report
Nov 15, 2023 05:30
Anebulo Pharmaceuticals | 8-K: Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2024 Financial Results and Recent Updates
Nov 15, 2023 05:19
Anebulo Pharmaceuticals | ARS: Annual Report to Security Holders
Oct 30, 2023 21:31
Anebulo Pharmaceuticals | DEF 14A: Definitive information statements
Oct 30, 2023 21:22
Anebulo Pharmaceuticals | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Oct 20, 2023 05:18
Anebulo Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer Cunningham, Richard Anthony
Oct 12, 2023 05:25
Anebulo Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Chief Executive Officer Cunningham, Richard Anthony
Oct 12, 2023 05:23
Anebulo Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director SHAH BIMAL R.
Oct 11, 2023 09:49
Anebulo Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director SHAH BIMAL R.
Oct 11, 2023 09:46
Anebulo Pharmaceuticals | 8-K: Current report
Oct 7, 2023 04:10
Anebulo Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Chief Financial Officer George Dan
Oct 3, 2023 05:01
Anebulo Pharmaceuticals | 8-K: Current report
Sep 29, 2023 06:17
Anebulo Pharmaceuticals | 10-K: FY2023 Annual Report
Sep 23, 2023 04:05
Anebulo Pharmaceuticals | 8-K: Anebulo Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Recent Updates
Sep 21, 2023 04:15
No Data
No Data